DuPont Launches New Liveo™ Pharma TPE Ultra-Low Temp Tubing for the Biopharma Industry

01.04.25 15:00 Uhr

Werte in diesem Artikel
Aktien

69,07 EUR 0,05 EUR 0,07%

Sterilizable, weldable, sealable thermoplastic elastomer tubing intended for biopharmaceutical processing applications that require low temperatures

WILMINGTON, Del., April 1, 2025 /PRNewswire/ -- DuPont (NYSE:DD) today announced it has launched DuPont Liveo Pharma TPE Ultra-Low Temp Tubing, a new thermoplastic elastomer tubing designed to withstand the low temperatures required for many of today's biopharmaceutical processing applications.

DuPont Logo (PRNewsfoto/DuPont)

Sterilizable, weldable, sealable Liveo Pharma TPE Ultra-Low Temp Tubing is an ISO Class 7 cleanroom-manufactured tubing that offers improved elastomer toughness and ductility down to -86 °C; resistance to bend, crush and impact at -80 °C; good pumpability and low spallation; and excellent burst pressure resistance and chemical resistance. The phthalate-free tubing's purity and regulatory data include USP Class VI standards, extractables USP <665>, elemental impurities USP <232> and Biocompatibility ISO 10993 (part 5, 6, 11, 23), among others. A comprehensive data package is available to facilitate qualification and validation.

"In recent years, there's been increasing demand for high-purity materials that can meet the biopharmaceutical processing industry's needs for low-temperature exposure," said Diana Salvadori, DuPont Global Senior Product Marketing Manager for Biopharma Processing. "With our new Liveo™ Pharma TPE Ultra-Low Temp Tubing, DuPont is offering an additional thermoplastic elastomer tubing option for fluid transport and single-use bioprocessing applications, facilitating adoption and compatibility with alternative TPE tubing offerings."

Liveo™ Pharma TPE Ultra-Low Temp Tubing is the second TPE tubing product launched by DuPont in recent years, joining Liveo™ Pharma TPE Tubing in the company's portfolio of solutions for biopharma processing applications – which also includes numerous silicone-based tubing and overmolded assembly (OMA) products.

"DuPont's TPE tubing products complement our silicone-based Liveo™ Pharma range – and they are produced under the same high-quality principles as our products that already are known and trusted by the biopharma industry," Salvadori said.

To learn more about new Liveo Pharma TPE Ultra-Low Temp Tubing, read the product brochure – which includes detailed features and benefits, purity and regulatory data, typical properties, comprehensive performance data, and more – at liveo.dupont.com.

About DuPont™ Liveo™ Healthcare Solutions
DuPont Liveois a globally recognized leader in technology for a broad range of innovations in medical devices, biopharmaceutical processing and pharmaceutical solutions. DuPont high-performance materials help create safer healthcare environments and protect the health of patients and healthcare providers worldwide. We help enable smarter healthcare and positive patient outcomes. More information can be found at liveo.dupont.com

About DuPont
DuPont (NYSE: DD) is a global innovation leader with technology-based materials and solutions that help transform industries and everyday life. Our employees apply diverse science and expertise to help customers advance their best ideas and deliver essential innovations in key markets including electronics, transportation, construction, water, healthcare and worker safety. More information about the company, its businesses and solutions can be found at www.dupont.com. Investors can access information included on the Investor Relations section of the website at investors.dupont.com.

DuPont™, the DuPont Oval Logo, and all trademarks and service marks denoted with ™, SM or ® are owned by affiliates of DuPont de Nemours, Inc. unless otherwise noted.

 

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/dupont-launches-new-liveo-pharma-tpe-ultra-low-temp-tubing-for-the-biopharma-industry-302415725.html

SOURCE DuPont

In eigener Sache

Übrigens: DuPont de Nemours und andere US-Aktien sind bei finanzen.net ZERO sogar bis 23 Uhr handelbar (ohne Ordergebühren, zzgl. Spreads). Jetzt kostenlos Depot eröffnen und als Geschenk eine Gratisaktie erhalten.

Ausgewählte Hebelprodukte auf DuPont de Nemours

Mit Knock-outs können spekulative Anleger überproportional an Kursbewegungen partizipieren. Wählen Sie einfach den gewünschten Hebel und wir zeigen Ihnen passende Open-End Produkte auf DuPont de Nemours

NameHebelKOEmittent
NameHebelKOEmittent
Wer­bung

Nachrichten zu DuPont de Nemours

Wer­bung

Analysen zu DuPont de Nemours

DatumRatingAnalyst
04.10.2021DuPont de Nemours OverweightJP Morgan Chase & Co.
20.08.2019DowDuPont OutperformCowen and Company, LLC
25.06.2019DowDuPont NeutralMonness, Crespi, Hardt & Co.
10.06.2019DowDuPont OutperformCowen and Company, LLC
06.02.2019DowDuPont Market PerformCowen and Company, LLC
DatumRatingAnalyst
04.10.2021DuPont de Nemours OverweightJP Morgan Chase & Co.
20.08.2019DowDuPont OutperformCowen and Company, LLC
10.06.2019DowDuPont OutperformCowen and Company, LLC
12.10.2018DowDuPont buyDeutsche Bank AG
29.03.2018DowDuPont OutperformBMO Capital Markets
DatumRatingAnalyst
25.06.2019DowDuPont NeutralMonness, Crespi, Hardt & Co.
06.02.2019DowDuPont Market PerformCowen and Company, LLC
12.09.2017DowDuPont NeutralMonness, Crespi, Hardt & Co.
31.05.2017Dow Chemical Market PerformCowen and Company, LLC
26.04.2017DuPont (E I DuPont de Nemours and Sector PerformRBC Capital Markets
DatumRatingAnalyst
05.01.2009Dow Chemical verkaufenEuro am Sonntag
11.04.2007Dow Chemical verkaufenHamburger Sparkasse
03.02.2006Update Rohm and Haas Co.: ReduceUBS
07.07.2005Update Rohm and Haas Co.: SellLongbow

Um die Übersicht zu verbessern, haben Sie die Möglichkeit, die Analysen für DuPont de Nemours nach folgenden Kriterien zu filtern.

Alle: Alle Empfehlungen

Buy: Kaufempfehlungen wie z.B. "kaufen" oder "buy"
Hold: Halten-Empfehlungen wie z.B. "halten" oder "neutral"
Sell: Verkaufsempfehlungn wie z.B. "verkaufen" oder "reduce"
mehr Analysen